Simunovic Z Laser Center, Locarno, Switzerland. Journal of Clinical Laser Medicine and Surgery (Aug. 1996) 14(4):163-167. Among the various methods of application techniques in LLLT (He-Ne 632.8 nm visible red or infrared 820-830 nm continuous wave and 904 nm pulsed emission) there are very promising “trigger points”, i.e., myofascial zones of particular sensibility and of highest projection of focal pain points, due to ischemic conditions. The effect of LLT and the results obtained after clinical treatment of >200 patients (headaches and facial pain, skeletomuscular ailments, myogenic neck pain, shoulder and arm pain, epicondylitis, tenosynovitis, low back and radicular pain, Achilles tendonitis) to whom the “trigger points” were applied were better than expected. It was also observed that rigidity decreases, mobility is restored (functional recovery), and spontaneous or induced pain decreases or even disappears, by movement. LLLT improves local microcirculation and it can also improve oxygen supply to hypoxic cells in the treated areas and can remove collected waste products. Normalization of the microcirculation interrupts the “circulus vitiosus” of the origin of the pain and its development (Melzak: muscular tension->pain->increased tension->increased pain, etc.). Results measured according to VAS/VRS/PTM: in acute pain, diminished >70%; in chronic pain >60%. Clinical effectiveness depends […]
MISSOURI CITY, Texas – April 10, 2002 – The Texas Board of Chiropractic Examiners has determined that MicroLight Corporation of America’s ML 830® low-level laser is within the scope of chiropractic care, the company announced today. “This represents a major breakthrough in the treatment of Carpal Tunnel Syndrome in the chiropractic profession,” said MicroLight President Mike Barbour. “This will allow more than 4,000 chiropractors in the state of Texas access to the ML 830® patented laser technology.” MicroLight is the only company that has received FDA clearance to market low-level laser therapy for non-surgical treatment of Carpal Tunnel Syndrome, or CTS. CTS is the No. 1 repetitive-stress injury problem in the workforce, costing the U.S. health care industry more than $10 billion annually.
Click on the following link to read the clinical trial results on the Hypothesis: Reduction in the perception of pain can be achieved with specific applications of Low Level Laser Therapy (LLLT) at ML830nm® for certain conditions. http://www.dcorthoacademy.com/e-Journal/sept05.pdf
by Richard Martin, BS, CLT Practical Pain Management, Nov/Dec 2003 Injured cells and tissues have greater affinity for LLLT than healthy cells and tissues. LLLT in the treatment of inflammation, pain and healing is a highly integrated process, but the author separates those processes categorically for identification. Acute Inflammation Reduction (flowchart provided in the original article) – After injury, tissues initiate a series of biological responses and cellular membrane reactions which manifest in a combination of edema, inflammation, pain and functional debility. LLLT mediates by: (1) Stabilizing cellular membranes; (2) Enhancing molecule ATP production and synthesis; (3) Stimulating vasodilation via increased Histamine, Nitric Oxide and Serotonin; (4) Accelerating leukocytic activity; (5) Increasing Prostaglandin synthesis; (6) Reducing Interleukin-1; (7) Enhancing lymphocyte response; (8) Increasing angiogenesis; (9) Modulation temperature; (10) Enhancing superoxide dismutase levels; and (11) Decreasing C-reactive protein and neopterin levels. Pain Reduction (flowchart provided in the original article) – Evidence justifies a conclusion that LLLT reduces pain by combination of processes: (1) Increase in b-Endorphins; (2) Blocked depolarization of C-fiber afferent nerves; (3) Increased nitric oxide production; (4) Increased nerve cell action potential; (5) Axonal sprouting and nerve cell regeneration; (6) Decreased Bradykinin levels; (7) Increased release of acetylcholine; […]
Simunovic Z and Trobonjaca T Lasers in Surgery and Medicine (2002) Supplement 14, Atlanta, Georgia The aim of this pilot study was to compare the efficacy of Low Level Laser therapy (LLLT), Transcutaneous Electro-Neural Stimulation (TENS), visible incoherent polarized (VIP) light and placebo in the treatment of lateral epicondylitis-tennis elbow. The patient population (n=120) was randomly allocated into four groups according to treatment applied. The therapy lasted three weeks per each treatment modality, where total number of treatments per patient was twelve (5+4+3 per three weeks). LLLT was applied as trigger points technique in all patients, using an infrared diode laser in a dosage of 4 J/point. TENS was applied using gummy plates in the same sizes and by exactly measuring the amount of mA, mV and Hertz in all patients. VIP light was applied in a dosage of 4/J.cm2 . Placebo was applied by using a laser device with no active laser emission. All patients suffered from chronic form of lateral epicondylitis, with x-ray proved no changes on the cervical spine. The outcome measurement was focused on the level of pain relief, estimated according to the Visual Analogue Scale (VAS). The results have demonstrated that the highest percentage […]